Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo
Botulinum neurotoxins are one of the most potent toxins found in nature, with broad medical applications from cosmetics to the treatment of various neuropathies. Additionally, these toxins are classified as Category A-Tier 1 agents, with human lethal doses calculated at as little as 90 ng depending...
Main Authors: | Andrew W Hudacek, Fetweh H Al-Saleem, Mallory Willet, Travis Eisemann, Jeffrey A Mattis, Lance L Simpson, Matthias J Schnell |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050116301140 |
Similar Items
-
Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain.
by: Sharad P Adekar, et al.
Published: (2008-08-01) -
Recombinant botulinum neurotoxin serotype A1 in vivo characterization
by: Cindy Périer, et al.
Published: (2021-10-01) -
On Botulinum Neurotoxin Variability
by: Cesare Montecucco, et al.
Published: (2015-02-01) -
New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency
by: David Burgin, et al.
Published: (2021-11-01) -
Production and characterization of cell-penetrating recombinant botulinum neurotoxin type A
by: Xuan Wei, et al.
Published: (2023-03-01)